Ranitidina Comprimidos
Anti-ulcer agent
Ranitidine is an H2 receptor antagonist with anti-ulcer action that reduces gastric acid secretion. Its effect is produced by blocking H2 receptors in the parietal cells, which reduces acidity and helps protect the gastric mucosa.
TARGET SPECIES
Dogs and cats.
DOSAGE FORM
Flavoured, scored tablet.
HOW SUPPLIED
Box containing 10 tablets in blister packs. Box containing 100 tablets in blister packs.
DIFFERENTIATORS
BENEFITS AND COMPETITIVE ADVANTAGES
Versatile use: indicated for multiple conditions.
Flavoured tablets.
Flavoured tablets.
Versatile use: indicated for multiple conditions.
Flavoured tablets.
TECHNICAL DETAILS
Information
COMPOSITION
– Ranitidine hydrochloride 50 mg.
– Excipients q.s. for 1 tablet.
– Excipients q.s. for 1 tablet.
DOSAGE AND ADMINISTRATION
Administer orally, alone or mixed with food.
Dogs: 2 mg/kg every 12 hours, equivalent to 1 tablet per 25 kg of body weight every 12 hours.
Cats: 3.5 mg/kg every 12 hours, equivalent to ¼ tablet per 3 kg of body weight every 12 hours.
Treatment may be started parenterally and continued via the oral route.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
Dogs: 2 mg/kg every 12 hours, equivalent to 1 tablet per 25 kg of body weight every 12 hours.
Cats: 3.5 mg/kg every 12 hours, equivalent to ¼ tablet per 3 kg of body weight every 12 hours.
Treatment may be started parenterally and continued via the oral route.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
- Joint Health
- Opioid Pain Management
- NSAID Pain Management
- Neuropathic Pain
- Steroidal Anti-inflammatory Drugs
- Antibiotics
- Gastrointestinal Health
- Hepatic Health
- Integrative Functional Supplementation
- Vitamins and Minerals
- Omega
- Laxatives
- Anticholinergic – Antispasmodics
- Hemostatic Agents
- Internal Antiparasitics
- External Antiparasitics
- Hemostatic Agent
Ranitidina Comprimidos
TARGET SPECIES
Dogs and cats.
DOSAGE FORM
Flavoured, scored tablet.
HOW SUPPLIED
Box containing 10 tablets in blister packs. Box containing 100 tablets in blister packs.
Anti-ulcer agent
Ranitidine is an H2 receptor antagonist with anti-ulcer action that reduces gastric acid secretion. Its effect is produced by blocking H2 receptors in the parietal cells, which reduces acidity and helps protect the gastric mucosa.
Versatile use: indicated for multiple conditions.
Flavoured tablets.
Flavoured tablets.
Versatile use: indicated for multiple conditions.
Flavoured tablets.
TECHNICAL DETAILS
Information
COMPOSITION
– Ranitidine hydrochloride 50 mg.
– Excipients q.s. for 1 tablet.
– Excipients q.s. for 1 tablet.
DOSAGE AND ADMINISTRATION
Administer orally, alone or mixed with food.
Dogs: 2 mg/kg every 12 hours, equivalent to 1 tablet per 25 kg of body weight every 12 hours.
Cats: 3.5 mg/kg every 12 hours, equivalent to ¼ tablet per 3 kg of body weight every 12 hours.
Treatment may be started parenterally and continued via the oral route.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
Dogs: 2 mg/kg every 12 hours, equivalent to 1 tablet per 25 kg of body weight every 12 hours.
Cats: 3.5 mg/kg every 12 hours, equivalent to ¼ tablet per 3 kg of body weight every 12 hours.
Treatment may be started parenterally and continued via the oral route.
Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
